ARPC3P2

Across TCGA pan-cancer cohorts, ARPC3P2 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated ARPC3P2 data layer.

The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher ARPC3P2 RNA is associated with better overall survival. In most high-consensus cancer types, elevated ARPC3P2 expression acts as an unfavorable survival marker, although some lineages such as CESC and BLCA show a favorable association.

CESC, BLCA, and MESO are the cancer types where ARPC3P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CESC	OS	Tertile	All	0.950	0.816	<.001	46	view →
BLCA	DFS	Quartile	III,IV	0.500	0.217	.021	20	view →
MESO	OS	Quartile	III,IV	0.368	0.614	.013	18	view →
UCS	DFS	Tertile	IV	0.871	0.321	.024	18	view →
THCA	OS	Median	III,IV	1.000	0.944	.004	17	view →
ACC	DFS	Tertile	III,IV	0.774	0.214	<.001	15	view →
COAD	DFS	Tertile	All	0.789	0.472	.015	10	view →
LGG	DFS	Median	All	0.766	0.871	.009	8	view →
SKCM	OS	Quartile	III,IV	0.926	0.681	.014	6	view →
READ	OS	Median	IV	0.504	0.814	.030	5	view →
THYM	OS	Median	All	1.000	0.667	.008	4	view →
LUAD	DFS	Quartile	III,IV	0.541	0.182	.048	4	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

ARPC3P2–CESC (OS)

Open the CESC breakdown →